Title 21

PART 20 SUBPART F

Subpart F - Availability of Specific Categories of Records

• 5 U.S.C. 552; 18 U.S.C. 1905; 19 U.S.C. 2531-2582; 21 U.S.C. 321-393, 1401-1403; 42 U.S.C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 263b-263n, 264, 265, 300u-300u-5, 300aa-1.
• 42 FR 15616, Mar. 22, 1977, unless otherwise noted.

21:1.0.1.1.17.6.63.1	SECTION 20.100	20.100 Applicability; cross-reference to other regulations.
21:1.0.1.1.17.6.63.2	SECTION 20.101	20.101 Administrative enforcement records.
21:1.0.1.1.17.6.63.3	SECTION 20.102	20.102 Court enforcement records.
21:1.0.1.1.17.6.63.4	SECTION 20.103	20.103 Correspondence.
21:1.0.1.1.17.6.63.5	SECTION 20.104	20.104 Summaries of oral discussions.
21:1.0.1.1.17.6.63.6	SECTION 20.105	20.105 Testing and research conducted by or with funds provided by the Food and Drug Administration.
21:1.0.1.1.17.6.63.7	SECTION 20.106	20.106 Studies and reports prepared by or with funds provided by the Food and Drug Administration.
21:1.0.1.1.17.6.63.8	SECTION 20.107	20.107 Food and Drug Administration manuals.
21:1.0.1.1.17.6.63.9	SECTION 20.108	20.108 Agreements between the Food and Drug Administration and other departments, agencies, and organizations.
21:1.0.1.1.17.6.63.10	SECTION 20.109	20.109 Data and information obtained by contract.
21:1.0.1.1.17.6.63.11	SECTION 20.110	20.110 Data and information about Food and Drug Administration employees.
21:1.0.1.1.17.6.63.12	SECTION 20.111	20.111 Data and information submitted voluntarily to the Food and Drug Administration.
21:1.0.1.1.17.6.63.13	SECTION 20.112	20.112 Voluntary drug experience reports submitted by physicians and hospitals.
21:1.0.1.1.17.6.63.14	SECTION 20.113	20.113 Voluntary product defect reports.
21:1.0.1.1.17.6.63.15	SECTION 20.114	20.114 Data and information submitted pursuant to cooperative quality assurance agreements.
21:1.0.1.1.17.6.63.16	SECTION 20.115	20.115 Product codes for manufacturing or sales dates.
21:1.0.1.1.17.6.63.17	SECTION 20.116	20.116 Drug and device registration and listing information.
21:1.0.1.1.17.6.63.18	SECTION 20.117	20.117 New drug information.
21:1.0.1.1.17.6.63.19	SECTION 20.118	20.118 Advisory committee records.
21:1.0.1.1.17.6.63.20	SECTION 20.119	20.119 Lists of names and addresses.
21:1.0.1.1.17.6.63.21	SECTION 20.120	20.120 Records available in Food and Drug Administration Public Reading Rooms.

---